Intriguingly, doxorubicin itself can also induce immunogenic cell death by a process that depends on the phagocytic uptake of apoptotic tumor cells by local DCs and subsequent priming of CD8+ T cells [38], [39], [40]. The gene discussed is CD8A; the disease is neoplasm.